Persistent de Quervain tenosynovitis induced by somatotropin treatment

---

Copy For Citation

Yurdakul O. V., Ayture L., YALCINKAYA E. Y.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, vol.30, no.11, pp.1223-1226, 2017 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 30 Issue: 11
• Publication Date: 2017
• Doi Number: 10.1515/jpem-2017-0085
• Journal Name: JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.1223-1226
• Bezmialem Vakıf University Affiliated: Yes

Abstract

Background: Growth hormone deficiency is a well-known clinical entity that is usually treated with somatotropin (growth hormone). Growth hormone has some frequent side effects such as intracranial hypertension, lymphedema and diabetes mellitus.